Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,340 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine.
Valent P, Akin C, Nedoszytko B, Bonadonna P, Hartmann K, Niedoszytko M, Brockow K, Siebenhaar F, Triggiani M, Arock M, Romantowski J, Górska A, Schwartz LB, Metcalfe DD. Valent P, et al. Among authors: hartmann k. Int J Mol Sci. 2020 Nov 27;21(23):9030. doi: 10.3390/ijms21239030. Int J Mol Sci. 2020. PMID: 33261124 Free PMC article. Review.
Fas ligand (FasL, CD95L, APO-1L) expression in murine mast cells.
Wagelie-Steffen AL, Hartmann K, Vliagoftis H, Metcalfe DD. Wagelie-Steffen AL, et al. Among authors: hartmann k. Immunology. 1998 Aug;94(4):569-74. doi: 10.1046/j.1365-2567.1998.00559.x. Immunology. 1998. PMID: 9767446 Free PMC article.
Pediatric mastocytosis.
Hartmann K, Metcalfe DD. Hartmann K, et al. Hematol Oncol Clin North Am. 2000 Jun;14(3):625-40. doi: 10.1016/s0889-8588(05)70299-9. Hematol Oncol Clin North Am. 2000. PMID: 10909043 Review.
The European Competence Network on Mastocytosis (ECNM).
Valent P, Arock M, Bischoff SC, Bühring HJ, Brockow K, Escribano L, Födinger M, Grabbe J, Hartmann K, Henz BM, Horny HP, Kluin-Nelemans HC, Lima M, Marone G, Orfao A, Parwaresch RM, Sillaber C, Sotlar K, Sperr WR, Triggiani M, Van Doormaal JJ, Wolff K, Zuberbier T. Valent P, et al. Among authors: hartmann k. Wien Klin Wochenschr. 2004 Oct 30;116(19-20):647-51. doi: 10.1007/s00508-004-0253-3. Wien Klin Wochenschr. 2004. PMID: 15941072
Mast cell apoptosis.
Gerbaulet A, Hartmann K, Mekori YA. Gerbaulet A, et al. Among authors: hartmann k. Methods Mol Biol. 2006;315:407-23. doi: 10.1385/1-59259-967-2:407. Methods Mol Biol. 2006. PMID: 16110173
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.
Valent P, Akin C, Escribano L, Födinger M, Hartmann K, Brockow K, Castells M, Sperr WR, Kluin-Nelemans HC, Hamdy NA, Lortholary O, Robyn J, van Doormaal J, Sotlar K, Hauswirth AW, Arock M, Hermine O, Hellmann A, Triggiani M, Niedoszytko M, Schwartz LB, Orfao A, Horny HP, Metcalfe DD. Valent P, et al. Among authors: hartmann k. Eur J Clin Invest. 2007 Jun;37(6):435-53. doi: 10.1111/j.1365-2362.2007.01807.x. Eur J Clin Invest. 2007. PMID: 17537151 Review.
Mastocytosis: a disease of the hematopoietic stem cell.
Horny HP, Sotlar K, Valent P, Hartmann K. Horny HP, et al. Among authors: hartmann k. Dtsch Arztebl Int. 2008 Oct;105(40):686-92. doi: 10.3238/arztebl.2008.0686. Epub 2008 Oct 3. Dtsch Arztebl Int. 2008. PMID: 19623287 Free PMC article.
Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trial.
Hartmann K, Siebenhaar F, Belloni B, Brockow K, Eben R, Hartmann B, Ruëff F, Schoepke N, Staubach P, Weber A, Maurer M. Hartmann K, et al. Among authors: hartmann b. Br J Dermatol. 2010 Jan;162(1):185-90. doi: 10.1111/j.1365-2133.2009.09434.x. Epub 2009 Aug 3. Br J Dermatol. 2010. PMID: 19785605 Clinical Trial.
1,340 results